Clinical trial
A Prospective, Randomized Clinical Trial Comparing Rivaroxaban vs Warfarin in High Risk Patients With Antiphospholipid Syndrome
NCT02157272 is registered in ClinicalTrials.gov with University of Padova as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized Clinical Trial Comparing Rivaroxaban vs Warfarin in High Risk Patients With Antiphospholipid Syndrome
- Lead sponsor
- University of Padova
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- December 31, 2014
- Completion date
- January 25, 2018
- Enrollment
- 121 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.